Get Your Own Businessabc AI Visibility ID
Boost AI visibility, credibility, and discoverability
An American life sciences company that provides instruments, software, services, and consumables for the entire laboratory workflow.
Agilent Technologies addresses the scientific and laboratory management needs of analytical scientists and clinical researchers. Agilent provides laboratory solutions to meet the needs of analytical scientists and clinical researchers worldwide. Agilent works closely with customers to help address global trends that impact human health and the environment and to anticipate future scientific needs. Agilent's solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management.
1999: Agilent Technologies was founded in May 1999 and is headquartered in Santa Clara, CA, United States. The split went into effect on November 1--the beginning of Agilent's and HP's fiscal year--and Agilent had its initial public offering (IPO) on November 18, 1999. In 1999 HP announced a strategic realignment and the creation of a separate company, Agilent Technologies Inc., which consisted of HP's test and measurement, semiconductor, chemical analysis, and healthcare businesses. 18, 1999 as the largest initial public offering (IPO) in Silicon Valley history. Following its successful IPO in 1999, Agilent Technologies becomes a fully independent measurement company focusing on high-growth markets in communications, electronics, and life sciences.
2000: In August 2000, Agilent announced the acquisition of the eCamera business unit of PhotoAccess.com Corp. For its fiscal fourth quarter ending October 31, 2000, Agilent reported that quarterly net income more than doubled to $305 million, compared to $146 million in the previous year's fourth quarter. For fiscal 2000 ending October 31, Agilent's sales of communications test equipment rose 55 percent, making it the company's fastest growing business. Also in December 2000 Agilent sold its Automation Integration Software (AIS) business to Verano. Toward the end of 2000 Agilent announced it would divest its unprofitable healthcare products business for $1.7 billion. Earlier in 2000 the company had created a new Life Sciences Business Unit as part of its Chemical Analysis Group to focus on the demand for its life sciences products.
2001: The sale of the healthcare products group, which was headquartered in Andover, Massachusetts, was expected to close by mid-2001. In 2001, in midst of this downsizing, Agilent sold its health care and medical products organization to Philips Medical Systems, and was noted as having a valuation of about $11 billion.
2004: The product lines affected included the automated optical inspection, solder paste inspection, and automated X-ray products [5DX] in 2004.
2005: Also in August 2005, Agilent sold its 47% stake in the light-emitting diode manufacturer Lumileds to Philips for $1 billion. Also in August 2005, Agilent announced a plan to divest its semiconductor test business, composed of both the system-on-chip and memory test market areas.
2006: Agilent listed the new company as Verigy on NASDAQ in mid-2006.
2009: In 2009, Agilent announced the closure of a subsection of its Test & Measurement division.
2012: On May 17, 2012, Agilent agreed to buy Dako, a Danish cancer diagnostics company, for $2.2 billion, to expand its presence in the life sciences industry.
2013: On September 19, 2013, Agilent announced its decision to separate into two publicly traded companies: Agilent, a life sciences, diagnostics, and applied markets company, and an electronic measurement company. In 2013, Agilent Technologies announces it will split into two separate pure-play measurement companies.
2014: On October 14, 2014, the company announced that it is exiting its Nuclear Magnetic Resonance business. It is listed on the New York Stock Exchange on November 3, 2014, with ticker symbol KEYS. On November 1, 2014, in a special dividend distribution of all outstanding shares of Keysight's common stock, Agilent shareholders received one share of Keysight common stock for every two shares of Agilent common stock held as of close of business October 22, 2014.
2015: In September 2015, the company announced it would acquire Seahorse Bioscience for $235 million.
2016: On July 7, 2016, Agilent announced that they had acquired U.K. based Cobalt Light Systems, which develops and manufactures Raman spectroscopy instruments, for £40 million in cash.
2017: Keysight restores its headquarters and manufacturing operations without a single order being cancelled amid evacuations and building damage resulting from the devastating 2017 Santa Rosa Tubbs fire.
2018: In January 2018, the company announced it would acquire Luxcel Biosciences, increasing the company's cell analysis portfolio. Marie Hattar, Keysight’s first Chief Marketing Officer, is honored with the 2018 Golden Bridge’s Executive of the Year (Woman) Award, Bronze
2019: In August 2019, Agilent acquired US-based BioTek Instruments, a designer, manufacturer, and distributor of life science instrumentation, for $1.165 billion.
According to Agilent Technologies, the company mission is: “to deliver trusted answers and insights that our customers to advance quality of life."
As stated in company website, Agilent Technologies vision is:" to advance goals through inter-related, multidisciplinary research programs, several of which are listed below and we invite you to explore further:"
Cellular Imaging and Analysis
Cellular Reprogramming
Fluidic Systems
Intelligent Systems
Mass Spectrometry
Nuclear Magnetic Resonance
Nucleic Acid Synthesis and Function
Omics
Pathology Workflow
Science Management Group
https://en.wikipedia.org/wiki/Agilent_Technologies
https://www.zippia.com/agilent-technologies-careers-293/
https://www.companieshistory.com/agilent-technologies/
https://sec.report/CIK/0001090872
https://companiesmarketcap.com/largest-companies-by-revenue/
https://www.bloomberg.com/profile/company/A:US
https://www.globaldata.com/company-profile/agilent-technologies-inc/
https://finance.yahoo.com/quote/A/profile/
https://www.reuters.com/markets/companies/A/
https://pitchbook.com/profiles/company/10663-30
